Key result
Ltbp2 deletion improves post-MI survival, preserves LVEF, and reduces myocardial fibrosis in mice.
Why the study?
Myocardial infarction initiates remote extracellular matrix remodeling and stiffening that contribute to heart failure, and it was unknown whether injury-induced LTBP2 regulates this remodeling or how it influences TGF-beta-dependent fibrosis despite lacking latent TGF-beta-binding capacity.
Does genetic deletion of Ltbp2 improve survival and attenuate maladaptive remote myocardial fibrosis, stiffening, and dysfunction in mice following myocardial infarction?
Does genetic deletion of Ltbp2 improve survival and attenuate maladaptive remote myocardial fibrosis, stiffening, and dysfunction in mice following myocardial infarction?
LTBP2 drives maladaptive remote myocardial fibrosis and stiffening after myocardial infarction by competitively limiting microfibrillar sequestration of latent TGF-beta, identifying the LTBP2–fibrillin-1 interaction as a potential therapeutic target to prevent post-MI heart failure.
Answers are grounded in this paper and cite their sources.
Ltbp2 deletion improves post-MI survival and function in mice; hypothesis-generating for LTBP2–fibrillin-1 targeting to limit remote fibrosis.
Myocardial infarction (MI) initiates ventricular remodeling that extends beyond the infarct into remote, viable myocardium, where diffuse extracellular matrix (ECM) remodeling and stiffening contribute to progressive dysfunction and heart failure. Latent transforming growth factor binding protein 2 (LTBP2) is an injury-induced, microfibril-associated ECM glycoprotein that, among the LTBP family, does not covalently bind latent TGF-?. We asked whether LTBP2 regulates remote remodeling after MI, and how a protein lacking latent TGF-??binding capacity could influence TGF-??dependent fibrosis. Wild-type and Ltbp2-null mice underwent permanent coronary ligation or sham surgery and were followed for 28 days by echocardiography and speckle-tracking strain analysis. Remote myocardium was assessed by histology, atomic force microscopy, and quantitative proteomics. Mechanism was interrogated in primary cardiac fibroblasts using a TGF-? reporter assay. Sufficiency was tested with a fibrillin-1?binding module of LTBP2 delivered as purified protein or by lentiviral expression. LTBP2 was induced in injury-activated cardiac fibroblasts and localized to infarct and remote myocardium by 7 days post-MI. Ltbp2 deletion improved 28-day survival (P=0.0272) where Ltbp2-null hearts showed preserved ejection fraction and faster diastolic strain rates, with protection concentrated in segments remote from the infarct. Remote myocardium contained less interstitial collagen and was significantly less stiff. Proteomic profiling showed enrichment of ECM organization and TGF-??responsive programs in wild-type hearts that was attenuated in knockouts. In fibroblasts, loss of LTBP2 increased LTBP1 matrix incorporation and shifted TGF-? from the soluble to the matrix-bound compartment; conversely, the minimal LTBP2 module bound fibrillin-1 directly and mobilized latent TGF-? from established matrix within 20 minutes. LTBP2 drives maladaptive remodeling of remote myocardium after MI by limiting matrix sequestration of latent TGF-? and expanding the activatable pool, resolving how an LTBP that does not bind latent TGF-? amplifies TGF-??dependent fibrosis. LTBP2 and its fibrillin-1 interaction surface may be tractable targets.
No takes yet. Share an insight, caveat, or question.
Ehsan et al. (2026) studied Post-myocardial infarction ventricular remodeling and cardiac fibrosis. Ltbp2 genetic deletion (Ltbp2-/-) vs. Wild-type (WT) mice was evaluated on 28-day post-myocardial infarction survival (p=0.0272). Genetic deletion of Ltbp2 significantly improved 28-day post-MI survival (P=0.0272), preserved ejection fraction, and reduced remote myocardial fibrosis and stiffness in mice.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: